About Omnicare’s Court-Supervised Process
Continuing Delivery of Safe and Reliable Pharmacy Services to All Customers
Protecting Our Business
Omnicare is taking steps to move forward and help ensure the continued delivery of safe and reliable pharmacy and clinical services to our customers and residents.
Specifically, Omnicare initiated a voluntary court-supervised Chapter 11 process to resolve issues related to the recent lawsuit in the U.S. District Court for the Southern District of New York. The Company also intends to use this process to address other financial challenges facing the broader long-term care pharmacy industry.


Supporting Our Customers and Residents
Omnicare has a proud history of providing industry-leading pharmacy and clinical care solutions to long-term care providers and residents. As we move through this process, our top priority continues to be providing safe and reliable pharmacy and clinical services.
Omnicare is Operating as Normal
From everyday care to specialized services – Omnicare is operating as normal, so our customers can focus on what matters most: meeting the healthcare needs of their long-term care residents.
Omnicare continues to focus on helping skilled nursing and assisted living providers navigate the increasing clinical, regulatory, and operational complexity of long‑term care through thoughtful pricing approaches, clinically meaningful programs, service models designed for the realities of long term care, and ongoing engagement with our customers.


Court-Supervised Sale Process
Following a comprehensive sale process, the Court approved GenieRx Holdings LLC, a joint partnership between private investment firm Milrose Capital LLC and health-care investment and management firm Integro Asset Management LLC, which does business as Integro Healthcare Services, as the buyer for the Omnicare business in full. The transaction is expected to close later this year, subject to regulatory approvals and customary closing conditions.